Breaking News, Financial News

Financial Report: AMRI 3Q

Large-scale manufacturing revenue up 14%

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI 3Q Revenues: $55.8 million (+11%)   3Q Loss: $2.1 million (loss of $5.9 million 3Q11)   YTD Revenues: $159.5 million (-1%)   YTD Loss: $5.7 million (loss of $7.9 million YTD11)   Comments: Total contract revenue for the quarter was $45.6 million, up 4%. Large Scale manufacturing revenue was $29.3 million (+14%). Discovery Services revenue was flat at $8.9 million. Development/Small-Scale Manufacturing revenue was $7.4 million (-20%). Royalty revenue in the quarter was $9.4 million (+45%) ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters